Better targets and drugs for improving stroke outcome?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1104036

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Infection is highly prevalent and is one of the leading causes of death in stroke. It is now recognised that stroke impairs the immune system, raising the possibility that reversing this impairment can decrease the rate of infection after stroke. Therefore, the focus of this project is to identify the signalling pathways that underlie abnormal immune function after stroke and also assess the potential of a novel pharmacological approach for reducing bacterial infection in stroke patients.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $1,085,972.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Basic Pharmacology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bacterial infection | host/pathogen interaction | stroke outcome | sympathetic nervous system | targeted therapy

Related Links